Compare PHVS & UTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PHVS | UTL |
|---|---|---|
| Founded | 2015 | 1984 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 899.9M |
| IPO Year | 2021 | N/A |
| Metric | PHVS | UTL |
|---|---|---|
| Price | $25.83 | $48.64 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | $39.44 | ★ $55.00 |
| AVG Volume (30 Days) | ★ 516.2K | 155.7K |
| Earning Date | 11-12-2025 | 02-09-2026 |
| Dividend Yield | N/A | ★ 3.73% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.85 |
| Revenue | N/A | ★ $502,000,000.00 |
| Revenue This Year | N/A | $5.98 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | ★ N/A | $16.93 |
| Revenue Growth | N/A | ★ 1.03 |
| 52 Week Low | $11.51 | $44.61 |
| 52 Week High | $29.80 | $59.99 |
| Indicator | PHVS | UTL |
|---|---|---|
| Relative Strength Index (RSI) | 53.13 | 46.42 |
| Support Level | $25.00 | $47.40 |
| Resistance Level | $27.45 | $48.82 |
| Average True Range (ATR) | 1.44 | 0.95 |
| MACD | 0.04 | -0.12 |
| Stochastic Oscillator | 56.24 | 35.48 |
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
Unitil Corp is a holding company, through its subsidiaries it is engaged in the local distribution of electricity and natural gas throughout its service territories in the states of New Hampshire, Massachusetts, and Maine. The Company has two operating and reportable segments: Utility Electric Operations and Utility Gas Operations. Majority of revenue is gained from Electric Segment.